Regenerative Wound Care Market to Grow with a CAGR of 5.97% through 2030
Increased
demand for treatment of acute and chronic wounds is expected to drive the
growth of Global Regenerative Wound Care Market in the forecast period, 2026-2030.
According to
TechSci Research report, “Regenerative Wound Care – Global Industry Size, Share,
Trends, Opportunity, and Forecast, 2030F”, Global Regenerative Wound Care Market stood at USD 10.27 billion in 2024 and is anticipated to grow with a CAGR of 5.97% in the forecast period through 2030. This
can be ascribed to the growing burden of non-healing chronic wounds.
Additionally, the increase in production of regenerative wound care products is
also boosting the growth of market in future years.
Furthermore, the rise in
ageing population, increased number of diabetic patients, increasing number of
surgical procedures performed, among others is further expected to support the
market growth during the forecast period. Technological
advancements such as the use of 3D printers for different tissue engineering
products coupled with use of more specialized and advanced printers such as
skin printers for the development of skin substitutes is expected to create
lucrative opportunities for the market growth.
Browse over XX
market data Figures spread through XX Pages and an in-depth TOC on "Global Regenerative Wound Care Market"
Global Regenerative Wound
Care Market is segmented into type, wound type, end user, regional distribution and company.
Based on End User, Ambulatory Surgical Centers (ASCs) are emerging as the fastest-growing end-user segment. This growth is driven by a broader shift in healthcare delivery that emphasizes outpatient care, cost efficiency, and patient convenience. ASCs provide an ideal setting for many advanced wound care procedures, which were traditionally confined to hospitals. With recent innovations in regenerative technologies—such as stem cell-based therapies, biological skin substitutes, and tissue-engineered platforms, many complex wound treatments can now be safely and effectively administered in outpatient settings. One of the key advantages of ASCs is their ability to offer high-quality care at a lower cost compared to inpatient hospital facilities. This has made them increasingly attractive to both healthcare providers and payers seeking to reduce the financial burden of chronic wound management. Furthermore, ASCs are often equipped with cutting-edge wound care technologies and staffed by specialized clinicians, allowing for a streamlined, efficient approach to wound healing. These centers also appeal to patients due to shorter waiting times, personalized care experiences, and the benefit of recovering at home, which contribute to higher patient satisfaction and improved clinical outcomes.
Based on the Region, the Asia Pacific region is witnessing the fastest growth in the global regenerative wound care market due to a combination of demographic shifts, rising disease burden, and improvements in healthcare infrastructure. One of the primary factors driving this growth is the increasing prevalence of chronic conditions such as diabetes and obesity, which significantly contribute to the incidence of chronic wounds like diabetic foot ulcers and pressure ulcers. These conditions are becoming more common in countries like India, China, and Southeast Asian nations, where rapid urbanization and lifestyle changes are leading to higher rates of metabolic disorders. Another major contributor is the region's aging population, particularly in countries such as Japan, South Korea, and China. Elderly individuals are more susceptible to chronic wounds due to reduced skin regeneration capabilities and a higher likelihood of coexisting medical conditions. As this demographic continues to expand, so too does the demand for advanced wound care solutions that promote faster and more effective healing.
Major companies operating in Global Regenerative Wound Care Market are:
- DeCell Technologies Inc.
- Avita Medical, Inc.
- Organogenesis, Inc.
- Histogen, Inc.
- RenovoDerm (Nanofiber Solutions, LLC)
- StemsysBio
- Koninklijke DSM N.V.
- MiMedx Group, Inc.
- 3M Company
- Smith & Nephew PLC
Download Free Sample Report
Customers can also request
for 10% free customization on this report.
“Governments and regulatory bodies are encouraging this trend by creating favorable environments for research and clinical adoption. For example, the U.S. FDA’s Regenerative Medicine Advanced Therapy (RMAT) designation accelerates the development and review of qualified regenerative products. Additionally, the Biomedical Advanced Research and Development Authority (BARDA) has funded several public-private collaborations to develop skin substitutes for treating burn wounds and battlefield injuries. Beyond chronic wounds, bioengineered skin is also being explored for cosmetic surgery, burn injuries, and even in reconstructive plastic surgery. This expansion into adjacent healthcare segments underlines the versatility and growing demand for bioengineered regenerative materials“, said Mr. Karan Chechi, Research Director of TechSci Research,
a research based global management consulting firm.
“Regenerative Wound Care Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Autologous Stem Cells, Biological Skin Substitutes, Tissue/Multiple Tissue Platform, Fetal Sin, Regenerative Wound Care Devices, Others), By Wound Type (Ulcers, Surgical & Traumatic Wounds, Burns), By End User (Hospitals, Ambulatory Surgical Centers, Burn Care Centers & Wound Clinics, Others), By Region and Competition, 2020-2030F”, has evaluated the future growth potential of Global Regenerative
Wound Care and provides statistics & information on market size,
structure, and future market growth. The report intends to provide cutting-edge
market intelligence and help decision makers take sound investment decisions.
Besides, the report also identifies and analyzes the emerging trends along with
essential drivers, challenges, and opportunities in Global Regenerative Wound Care.
Contact
TechSci Research LLC
420 Lexington Avenue, Suite 300,
New York, United States- 10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com